Sign-up to Receive
Our Latest Insights

CURE
VanEck Genomics and Healthcare Innovators UCITS ETF

Fund Description

Technology is transforming healthcare. Not only are genomic treatments for several diseases becoming more affordable, but also digitalized healthcare is growing fast. VanEck’s Genomics and Healthcare Innovators UCITS ETF invests in the businesses pioneering ways to treat disease and connect with patients.

  • Invest in genomics companies developing new ways to treat health problems such as genetic conditions, cancer and conditions related to ageing
  • Gain exposure to digital health services providers – delivering easy access to doctors, physiotherapists, nurses and pharmacists
  • Pure-play exposure to companies earning at least half their revenues from genomics- or e-healthcare-related industries
  • Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco


Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KIID and in the sales prospectus. Evolving of the market not guaranteed.



Underlying Index

MVIS® Global Future Healthcare ESG Index (MVFHCTR)

Fund Details
 

  • Fund Ticker

    CURE
  • Management Company

    VanEck Asset Management B.V.
  • Custodian

    State Street Custodial Services (Ireland) Limited
  • Domicile

    Ireland
  • UCITS Compliant

    Yes
  • Index Ticker

    MVFHCTR
  • Index Provider

    MarketVector Indexes
  • Rebalance Frequency

    Semi-Annually
1The "Net Asset Value" (NAV) of all ETFs is determined at the close of each business day, and represents the value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF 's intraday trading value. Investors should not expect to buy or sell ETF shares at NAV.

2The date the fund was launched prior to quotation on the stock exchange.

 
as of 07 Dec 2022

  • NAV1

    21.79
  • Shares Outstanding

    310,000
  • Number of Holdings

    60
  • Base Currency

    USD
  • Net Assets

    $6.8M
  • Product Structure

    Physical (Full Replication)
  • Income Treatment

    Reinvestment
  • Distribution Frequency

    None
  • Total Expense Ratio

    0.35%
  • ISA Eligibility

    Yes
  • SIPP Available

    Yes
  • UK Reporting Status

    Yes
  • UK Distributor

    Yes
  • SFDR Classification

    Article 9
  • Fact Sheet
  • VanEck Product List
  • Fund Holiday Calendar

Trading Information as of 07 Dec 2022

London
Stock Exchange
USD
Exchange Ticker CURE
ISIN IE000B9PQW54
SEDOL BQFP700
Bloomberg CURE LN
Reuters (RIC) CURE.L
Valor 121031038
Bloomberg iNAV CUREUSIV
Reuters iNAV CUREUSDINAV=SOLA
WKN A3DSGJ
Trading Currency USD
Last Traded Price 21.77
Day's Move 0.07
Volume 0
30 Day Volume 265
VWAP Volume 230
London
Stock Exchange
GBP
Exchange Ticker CURG
ISIN IE000B9PQW54
SEDOL BQFP711
Bloomberg CURG LN
Reuters (RIC) CURG.L
Valor 121031038
Bloomberg iNAV CUREUSIV
Reuters iNAV CUREUSDINAV=SOLA
WKN A3DSGJ
Trading Currency GBP
Last Traded Price 17.87
Day's Move 0.13
Volume 0
30 Day Volume 5
VWAP Volume 109
Deutsche
Börse
EUR
Exchange Ticker CURE
ISIN IE000B9PQW54
SEDOL BNG7JX1
Bloomberg CURE GY
Reuters (RIC) CURE.DE
Valor 121031038
Bloomberg iNAV CUREUSIV
Reuters iNAV CUREINAV=SOLA
WKN A3DSGJ
Trading Currency EUR
Last Traded Price 20.74
Day's Move 0.09
Volume 10
30 Day Volume 339
VWAP Volume 10
SIX
Swiss Exchange
CHF
Exchange Ticker CURE
ISIN IE000B9PQW54
SEDOL BNG7JZ3
Bloomberg CURE SE
Reuters (RIC) CURE.S
Valor 121031038
Bloomberg iNAV CUREUSIV
Reuters iNAV CUREUSDINAV=SOLA
WKN A3DSGJ
Trading Currency CHF
Last Traded Price 19.12
Day's Move -0.15
Volume 0
30 Day Volume 17
VWAP Volume 0
Borsa
Italiana
EUR
Exchange Ticker CURE
ISIN IE000B9PQW54
SEDOL BNG7JY2
Bloomberg CURE IM
Reuters (RIC) CURE.MI
Valor 121031038
Bloomberg iNAV CUREUSIV
Reuters iNAV CUREINAV=SOLA
WKN A3DSGJ
Trading Currency EUR
Last Traded Price 20.75
Day's Move 0.12
Volume 0
30 Day Volume 336
VWAP Volume 0

NAVs as of 07 Dec 2022

Base
Currency
NAV Daily
Change
NAV
YTD
Change
NAV
NAV Price
History
Total
Expense
Ratio
CURE USD $21.79 $0.17 / +0.80% +8.14%
0.35

Performance History* (%)

Month End as of 30 Nov 2022 1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVFHCTR (Index) 4.90 7.05 -21.71 -25.83 -- -- -- 8.73
Quarter End as of 30 Sep 2022 1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVFHCTR (Index) -5.85 -1.98 -31.14 -37.72 -- -- -- -4.38

Market Makers

Top 10 Holdings (%) as of 30 Nov 2022 View All Holdings »

Total Holdings: 60
Holding Name
Ticker
Shares Market Value
(USD)
% of Net
Assets
REGENERON PHARMACEUTICALS INC
REGN US
861
647,214 9.53
MODERNA INC
MRNA US
3,331
585,956 8.63
VERTEX PHARMACEUTICALS INC
VRTX US
1,805
571,102 8.41
DEXCOM INC
DXCM US
4,722
549,074 8.09
ILLUMINA INC
ILMN US
1,872
408,246 6.01
VEEVA SYSTEMS INC
VEEV US
2,029
386,240 5.69
BIONTECH SE
BNTX US
2,227
371,954 5.48
ALNYLAM PHARMACEUTICALS INC
ALNY US
1,335
294,488 4.34
INSULET CORP
PODD US
789
236,203 3.48
M3 INC
2413 JP
7,400
222,997 3.29
Top 10 Total (%) 62.95
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 30 Nov 2022

  • Country

    % of Net Assets
  • United States

    80.74
  • Germany

    6.00
  • China

    5.76
  • Japan

    3.33
  • United Kingdom

    1.42
  • Switzerland

    1.32
  • Australia

    0.70
  • Sweden

    0.56
  • Netherlands

    0.17
  • Other/Cash

    0.01

Sector Weightings (%) as of 30 Nov 2022

  • Sector

    % of Net Assets
  • Health Care

    94.5
  • Consumer Discretionary

    4.8
  • Materials

    0.4
  • Consumer Staples

    0.3
  • Other/Cash

    0.0